(openPR) - Juelich, 16th August 2007. DASGIP AG, a leading manufacturer of parallel bioreactor systems, expands its range of gassing solutions for fermentation and cell cultivation by introducing the new modules MX4/1 and MF4. MX4/1 supplies reactors up to pilot scale, while MF4 has been designed specifically to meet the requirements of industrial biotechnology.
DASGIP’s new gas mixing system MX4/1 complements their best-selling single module MX4/4. Both products provide a mass flow controlled mixture of air, oxygen, carbon dioxide and nitrogen. While MX4/4 serves four separate culture vessels, MX4/1 pipes the gas mixture into one reactor at a rate of up to 2,000 standard litres per hour (sL/hr). MX4/1 is thereby ideally suited for gassing requirements at pilot scale. Electronic mass flow controllers and set-points at each outlet enable precise and individual adjustment of oxygen and carbon dioxide concentrations, offering more reproducible results. Users can now also define the mixture components of incoming gases, e.g. artificial oxygen composed of 90% oxygen and 10% nitrogen in order to use gas mixtures according to their security standards.
The new DASGIP MF4 has been developed for processes requiring unconventional gasses such as methane and carbon monoxide in biofuel development. MF4 provides mass flow controlled gassing up to 2,000sL/hr for four parallel channels and users are free to select any four input gasses to suit their needs. Independent gas leads ensure different gases can be combined even though they would normally react with each other.
Both gas mixing appliances as well as the MF4 are equipped with sensitive pressure sensors to ensure gassing is automatically stopped when excess pressure occurs. This ensures a high measure of workplace and production safety when handling glass vessels and bags.
With its new products MX4/1 and MF4, the market leading MX4/4, and the gassing module RX2/4, DASGIP AG serves a broad range of users and requirements in cell cultivation and fermentation.
DASGIP will be demonstrating its new gassing systems at the Biotechnica 2007 in Hanover, Germany (9 - 11 October 2007, booth G25, hall 9).
DASGIP AG develops and manufactures technologically advanced Parallel Bioreactor Systems for the cultivation of microbial and mammalian cells at bench top and pilot scale. Process engineers, scientists and product developers from biotechnological, pharmaceutical and chemical companies as well as research institutions use DASGIP Parallel Bioreactor Systems for their biotechnological processes and benefit from increased productivity, high reproducibility, and ease of scale up, resulting in accelerated product development cycles.
DASGIP is located in Juelich (Germany) and Shrewsbury MA (USA).
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
